Back
Actuate Therapeutics, Inc. Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
6
ACTU
Actuate Therapeutics, Inc.
Last Price:
$3.84
Seasonality Move:
37.94%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ACTU is experiencing selling pressure, which indicates risk of future bearish movement.
Actuate Therapeutics, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 4.04 | Sell |
| 20-day SMA: | 4.3 | Sell |
| 50-day SMA: | 5.33 | Sell |
| 200-day SMA: | 6.97 | Sell |
| 8-day EMA: | 4.02 | Sell |
| 20-day EMA: | 4.35 | Sell |
| 50-day EMA: | 5.1 | Sell |
| 200-day EMA: | 6.55 | Sell |
Actuate Therapeutics, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.4 | Sell |
| Relative Strength Index (14 RSI): | 31.12 | Sell |
| Chaikin Money Flow: | -24044 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (4 - 4.94) | Sell |
| Bollinger Bands (100): | (4.97 - 7.29) | Sell |
Actuate Therapeutics, Inc. Technical Analysis
| Feb 13 | Feb 17 | Feb 18 | Feb 19 | Feb 20 | Feb 23 | Feb 24 | Feb 25 | Feb 26 | Feb 27 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb | ||||||||||
| 13 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | 27 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Actuate Therapeutics, Inc. Stock
Is Actuate Therapeutics, Inc. Stock a Buy?
-
Actuate Therapeutics, Inc. share price is 3.74 while ACTU 8-day simple moving average is 4.04, which is a Sell signal.
-
The stock price of ACTU is 3.74 while Actuate Therapeutics, Inc. 20-day SMA is 4.30, which makes it a Sell.
-
Actuate Therapeutics, Inc. 50-day simple moving average is 5.33 while ACTU share price is 3.74, making it a Sell technically.
-
ACTU stock price is 3.74 and Actuate Therapeutics, Inc. 200-day simple moving average is 6.97, creating a Sell signal.
ACTU Technical Analysis vs Fundamental Analysis
Sell
6
Actuate Therapeutics, Inc. (ACTU)
is a Sell
Is Actuate Therapeutics, Inc. a Buy or a Sell?
-
Actuate Therapeutics, Inc. stock is rated a SellThe current Actuate Therapeutics, Inc. [ACTU] share price is $3.74. The Score for ACTU is 6, which is 88% below its historic median score of 50, and infers higher risk than normal.
Actuate Therapeutics, Inc. Stock Info
Market Cap:
86.9M
Price in USD:
3.74
Share Volume:
24K
Actuate Therapeutics, Inc. 52-Week Range
52-Week High:
11.99
52-Week Low:
3.72
Sell
6
Actuate Therapeutics, Inc. (ACTU)
is a Sell
Actuate Therapeutics, Inc. Share Price Forecast
-
What is the Actuate Therapeutics, Inc. stock price today?The Actuate Therapeutics, Inc. stock price is 3.74 USD today.
-
Will ACTU stock go up or go down?Actuate Therapeutics, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Actuate Therapeutics, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Actuate Therapeutics, Inc. is overvalued.
Is Actuate Therapeutics, Inc. Stock a Buy?
-
Actuate Therapeutics, Inc. share price is 3.74 while ACTU 8-day exponential moving average is 4.02, which is a Sell signal.
-
The stock price of ACTU is 3.74 while Actuate Therapeutics, Inc. 20-day EMA is 4.35, which makes it a Sell.
-
Actuate Therapeutics, Inc. 50-day exponential moving average is 5.10 while ACTU share price is 3.74, making it a Sell technically.
-
ACTU stock price is 3.74 and Actuate Therapeutics, Inc. 200-day simple moving average is 6.55, creating a Sell signal.
Fundamental Analysis of Actuate Therapeutics, Inc.
Is Actuate Therapeutics, Inc. a good investment?
-
Analysts estimate an earnings increase this quarter of $0.04 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.05 per share, and a decrease next year of $0.37 per share.
Technical Analysis of Actuate Therapeutics, Inc.
Should I short Actuate Therapeutics, Inc. stock?
-
ACTU Moving Average Covergence Divergence (MACD) indicator is -0.4, suggesting Actuate Therapeutics, Inc. is a Sell
-
Actuate Therapeutics, Inc. Relative Strength Index (RSI) is 31.12, which suggest Actuate Therapeutics, Inc. is oversold
-
The Bollinger Bands (25) for Actuate Therapeutics, Inc. is (4 - 4.94), which suggest Actuate Therapeutics, Inc. is a Sell
-
The Bollinger Bands (100) for Actuate Therapeutics, Inc. is (4.97 - 7.29), which suggest Actuate Therapeutics, Inc. is a Sell
* Actuate Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.